middle.news
How SEEK’s $356m Zhaopin Impairment Shapes Its Growth Story
8:32am on Tuesday 17th of February, 2026 AEDT
•
Technology
Read Story
How SEEK’s $356m Zhaopin Impairment Shapes Its Growth Story
8:32am on Tuesday 17th of February, 2026 AEDT
Key Points
21% increase in sales revenue to $646.6 million
Adjusted profit from continuing operations up 35% to $104.1 million
Reported net loss of $177.9 million due to $356 million impairment on Zhaopin investment
Interim dividend raised by 13% to 27 cents per share
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
SEEK (ASX:SEK)
OPEN ARTICLE